BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 299940)

  • 1. [Methods of measurement of Willebrand activity on microtitration plates].
    Sultan Y; Rossi J
    Nouv Presse Med; 1977 Jan; 6(1):44-6. PubMed ID: 299940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological diagnosis of von Willebrand's disease (author's transl)].
    Castillo R; Maragall S; Liendo F; Ordinas A
    Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study on two methods of quantitative assay for von Willebrand factor using a washed-platelet-system and a fixed-washed-platelet-system (author's transl)].
    Kajikawa M; Taketomi Y; Ihara A; Nakagawa J; Fujimura K
    Rinsho Ketsueki; 1976 Aug; 17(8):868-75. PubMed ID: 1088552
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid assay for von Willebrand factor activity using formalin-fixed platelets and microtitration technic.
    Ramsey R; Evatt BL
    Am J Clin Pathol; 1979 Dec; 72(6):996-9. PubMed ID: 316281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Method of determining von Willebrand factor activity].
    Papaian LP
    Lab Delo; 1982; (5):275-8. PubMed ID: 6178881
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased platelet function and von Willebrand factor in vibration syndrome.
    Ikehata K; Kawauchi S; Kohno F; Nishiyama M; Ide N
    Tokushima J Exp Med; 1980 Jun; 27(1-2):23-8. PubMed ID: 6968462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quantitative determination of Willebrand factor activity in Willebrand's disease].
    Buchvarova V; Samama M; Lecrubier C
    Vutr Boles; 1976; 15(3):92-4. PubMed ID: 1086035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
    Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J
    J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nosographic and pathogenetic considerations on a case of von Willebrand-Jürgens disease].
    Mauro R; Volpe E; Valente A; Buonanno G
    Haematologica; 1969; 54(10):663-84. PubMed ID: 4994284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of F-ab-peroxidase conjugates for localizing the Willebrand factor in human platelets].
    Jeanneau C; Sultan Y
    Arch Anat Cytol Pathol; 1984; 32(1):53. PubMed ID: 6375588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Von Willebrand disease--a variation with an aberrant multimeric structure].
    Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
    Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhagic thrombocytic dystrophy (interaction of platelets and the Willebrand factor)].
    Caen J; Levy-Toledano S; Sultan Y; Bernard J
    Nouv Rev Fr Hematol; 1973; 13(4):595-602. PubMed ID: 4271109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of von Willebrand factor analysis in blood coagulo-fibrinolytic tests].
    Takahashi Y
    Nihon Rinsho; 1989 Dec; 48 Suppl():853-7. PubMed ID: 2622019
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of platelet functions: measurement of the adhesiveness of platelets to glass on whole blood (Salzman method)].
    Meyer D; Larrieu MJ
    Rev Fr Etud Clin Biol; 1967; 12(7):736-9. PubMed ID: 5299002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Ketsueki; 1977 May; 18(5):575-86. PubMed ID: 333144
    [No Abstract]   [Full Text] [Related]  

  • 17. Assay of ristocetin cofactor: experience with a platelet counting technique.
    Bird AR; Sacks R; Smith A
    Med Lab Sci; 1984 Jan; 41(1):38-45. PubMed ID: 6609295
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.
    Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ
    J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.